These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2816514

  • 1. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M, Felsenfeld AJ, Llach F.
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [Abstract] [Full Text] [Related]

  • 2. Aluminum administration in the rat separately affects the osteoblast and bone mineralization.
    Rodriguez M, Felsenfeld AJ, Llach F.
    J Bone Miner Res; 1990 Jan; 5(1):59-67. PubMed ID: 2309580
    [Abstract] [Full Text] [Related]

  • 3. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG.
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [Abstract] [Full Text] [Related]

  • 4. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG, Weisbrode SE.
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [Abstract] [Full Text] [Related]

  • 5. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA, Chavassieux PM, Chapuy MC, Boivin GY, Meunier PJ.
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [Abstract] [Full Text] [Related]

  • 6. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ, Machado L, Bover J, Trinidad P, Rodriguez M.
    Nephrol Dial Transplant; 1993 Aug; 8(4):325-34. PubMed ID: 8390007
    [Abstract] [Full Text] [Related]

  • 7. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB, Alfrey AC, Miller NL, Goodman WG.
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accelerated accumulation of aluminum by osteoid matrix in vitamin D deficiency. An animal model of aluminum toxicity.
    Hodsman AB, Anderson C, Leung FY.
    Miner Electrolyte Metab; 1984 Jan; 10(5):309-15. PubMed ID: 6493159
    [Abstract] [Full Text] [Related]

  • 10. The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat.
    Felsenfeld AJ, Machado L, Rodriguez M.
    J Am Soc Nephrol; 1991 Jan; 1(7):970-9. PubMed ID: 1883967
    [Abstract] [Full Text] [Related]

  • 11. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.
    Quarles LD, Dennis VW, Gitelman HJ, Harrelson JM, Drezner MK.
    J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143
    [Abstract] [Full Text] [Related]

  • 12. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [Abstract] [Full Text] [Related]

  • 13. Biological effects of aluminum on normal dogs: studies on the isolated perfused bone.
    Galceran T, Finch J, Bergfeld M, Coburn J, Martin K, Teitelbaum S, Slatopolsky E.
    Endocrinology; 1987 Jul; 121(1):406-13. PubMed ID: 3036473
    [Abstract] [Full Text] [Related]

  • 14. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR, Evans RA, Hills E, Wong SY, Alfrey AC.
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M, Charhon SA, Arlot M, Mainetti E, Chavassieux P, Chapuy MC, Meunier PJ.
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [Abstract] [Full Text] [Related]

  • 16. Experimental aluminum-induced bone disease: studies in vivo.
    Goodman WG.
    Kidney Int Suppl; 1986 Feb; 18():S32-6. PubMed ID: 3517461
    [Abstract] [Full Text] [Related]

  • 17. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ, Van de Vyver FL.
    Clin Nephrol; 1985 Feb; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [Abstract] [Full Text] [Related]

  • 18. Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat.
    Rodriguez M, Lorenzo V, Felsenfeld AJ, Llach F.
    J Bone Miner Res; 1990 Apr; 5(4):379-86. PubMed ID: 2343777
    [Abstract] [Full Text] [Related]

  • 19. Animal model of aluminum-induced osteomalacia: role of chronic renal failure.
    Robertson JA, Felsenfeld AJ, Haygood CC, Wilson P, Clarke C, Llach F.
    Kidney Int; 1983 Feb; 23(2):327-35. PubMed ID: 6842959
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.